Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aurinia Pharm Ord (NQ: AUPH ) 7.340 -0.020 (-0.27%) Streaming Delayed Price Updated: 2:01 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Aurinia Pharm Ord < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > NASDAQ: AUPH Long Term Investor Alert: Investigation of Potential Wrongdoing at Aurinia Pharmaceuticals Inc. August 15, 2022 San Diego, CA -- (SBWIRE) -- 08/15/2022 -- Certain directors of Aurinia Pharmaceuticals Inc. are under investigation over possible breaches of fiduciary duties. Via SBWire Karuna Therapeutics To $276? Plus SVB Leerink Almost Doubles Price Target On This Stock August 09, 2022 Mizuho boosted the price target for Karuna Therapeutics, Inc. (NASDAQ: KRTX) from $190 to $276. Karuna Therapeutics shares fell 1.3% to $238.00 in pre-market trading. Via Benzinga Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate August 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results August 04, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 01, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Why Aurinia Pharmaceuticals Stock Is Plunging July 26, 2022 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading lower Tuesday after the company received a notice regarding the U.S. Patent Office Patent Trial and Appeal Board's decision to institute... Via Benzinga Aurinia Pharmaceuticals Notification Regarding Inter Partes Patent Review July 26, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Stocks That Hit 52-Week Lows On Wednesday July 27, 2022 Wednesday saw 83 companies set new 52-week lows. Via Benzinga Aurinia Pharmaceuticals to Release Second Quarter 2022 Financial and Operational Results on August 4, 2022 July 25, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday July 27, 2022 Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. Via Benzinga Aurinia Announces Positive CHMP Opinion for LUPKYNIS® (voclosporin) for the Treatment of Adults with Active Lupus Nephritis in Europe July 22, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday July 18, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering... Via Benzinga Aurinia Pharmaceuticals Skids With Its Buyout Thesis Hanging By A Thread July 15, 2022 The company just hired three new executives, likely putting a buyout in the rearview. Via Investor's Business Daily Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session July 15, 2022 Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday. Via Benzinga Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance July 14, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Final Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Aurinia Pharmaceuticals Inc. (AUPH) Investors of Class Action and Last Day to Actively Participate June 13, 2022 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire AURINIA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Aurinia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm June 11, 2022 From Bragar Eagel & Squire, P.C. Via Business Wire AUPH FINAL DEADLINE TUESDAY: ROSEN, A LONGSTANDING LAW FIRM, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important June 14 Deadline in Securities Class Action - AUPH June 11, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal NASDAQ:AUPH Investor Notice: Deadline on June 14, 2022 in Lawsuit Against Aurinia Pharmaceuticals Inc. June 08, 2022 San Diego, CA -- (SBWIRE) -- 06/08/2022 -- The Shareholders Foundation announced that a deadline is coming up on June 14, 2022 in the lawsuit filed for certain investors of Aurinia Pharmaceuticals Inc.... Via SBWire Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 06, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire Aurinia Presents Data Demonstrating LUPKYNIS® (voclosporin) is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations June 03, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More May 30, 2022 Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... Via Benzinga ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Aurinia Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AUPH May 27, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress May 20, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara May 20, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Aurinia Pharmaceuticals Announces Presentations at the 2022 ERA Congress and the 2022 EULAR Congress May 16, 2022 From Aurinia Pharmaceuticals Inc. Via Business Wire INVESTOR DEADLINE: Aurinia Pharmaceuticals Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – AUPH May 13, 2022 From Robbins Geller Rudman & Dowd LLP Via Business Wire Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Aurinia Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm May 11, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal PreMarket Prep Stock Of The Day: Good News From Aurinia Pharmaceuticals In A Down Week May 10, 2022 Rarely mentioned in the recent chaos in the markets is the biotech sector. With a heavy emphasis in 2020 and 2021 on finding cures and treatments for COVID-19, major drug approvals from the FDA have... Via Benzinga 103 Biggest Movers From Yesterday May 11, 2022 Gainers Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
